FABIOR Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which patents cover Fabior, and when can generic versions of Fabior launch?
Fabior is a drug marketed by Mayne Pharma and is included in one NDA. There are three patents protecting this drug.
This drug has twenty-four patent family members in eighteen countries.
The generic ingredient in FABIOR is tazarotene. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the tazarotene profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fabior
A generic version of FABIOR was approved as tazarotene by TARO PHARMS on April 3rd, 2017.
Summary for FABIOR
International Patents: | 24 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 125 |
Clinical Trials: | 1 |
Patent Applications: | 4,324 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for FABIOR |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for FABIOR |
What excipients (inactive ingredients) are in FABIOR? | FABIOR excipients list |
DailyMed Link: | FABIOR at DailyMed |


Recent Clinical Trials for FABIOR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Actavis Inc. | Phase 3 |
Pharmacology for FABIOR
Drug Class | Retinoid |
Anatomical Therapeutic Chemical (ATC) Classes for FABIOR
US Patents and Regulatory Information for FABIOR
FABIOR is protected by three US patents.
Patents protecting FABIOR
Topical foam composition
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TOPICAL TREATMENT OF ACNE VULGARIS IN PATIENTS 12 YEARS OF AGE OR OLDER
Topical foam composition
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TOPICAL TREATMENT OF ACNE VULGARIS IN PATIENTS 12 YEARS OF AGE OR OLDER
Topical foam composition
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mayne Pharma | FABIOR | tazarotene | AEROSOL, FOAM;TOPICAL | 202428-001 | May 11, 2012 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Mayne Pharma | FABIOR | tazarotene | AEROSOL, FOAM;TOPICAL | 202428-001 | May 11, 2012 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Mayne Pharma | FABIOR | tazarotene | AEROSOL, FOAM;TOPICAL | 202428-001 | May 11, 2012 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for FABIOR
See the table below for patents covering FABIOR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Mexico | 340791 | COMPOSICION DE ESPUMA TOPICA. (TOPICAL FOAM COMPOSITION.) | ⤷ Try a Trial |
Portugal | 2400951 | ⤷ Try a Trial | |
Brazil | PI1008037 | composição de espuma tópica | ⤷ Try a Trial |
Denmark | 2400951 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 2010096868 | ⤷ Try a Trial | |
Japan | 2012518662 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for FABIOR
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0284288 | 12/1998 | Austria | ⤷ Try a Trial | PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: 1-22102, 1-22103 19970918; FIRST REGISTRATION: DE 37393.00.00, 37393.01.00 19961203 |
0284288 | SPC/GB98/002 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: TAZAROTENE : ETHYL 6-(2-(4,4-DIMETHYLTHIOCHROMAN-6-YL) ETHYNYL) NICOTINOATE; REGISTERED: DE 37393.00.00 19961203; DE 37393.01.00 19961203; UK 00426/0097 19970730; UK 00426/0096 19970730 |
0031058 | 98C0008 | Belgium | ⤷ Try a Trial | PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: NL22604 19970922; FIRST REGISTRATION: DE - 37393.00.00 19961203 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |